For the Inventor, By the Inventor

Enter assignee name

Napa, CA, United States of America

Transvivo, Inc.

Calculating rank

USPTO Granted Patents = 19

% Expired Patents = 73.7

EPO Patents = 1

Forward Citations = 740

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Reynolds G Gorsuch (19 out of 29 patents)

Harold W Peters (9 out of 15 patents)

Harold H Handley, Jr (9 out of 9 patents)

4. Tommy Gene Cooper (5 out of 20 patents)

5. Henry M Grage (4 out of 18 patents)

6. Jacob C Kearns (3 out of 3 patents)

7. Kris Venkat (3 out of 3 patents)

8. Harold H Handley (7 patents)

19 patents: Sort by Forward Citations

1. 8070706 - Apparatus and method for in-vivo plasmapheresis using periodic backflush containing anticoagulant (2011-12-06),

2. 7585412 - Specialized hollow fiber membranes for plasmapheresis and ultrafiltration (2009-09-08),

3. 7572374 - Anticoagulant and thrombo-resistant hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration (2009-08-11),

4. 7481936 - Method and apparatus for patient fluid management (2009-01-27),

5. 7476210 - Apparatus and method for in-vivo plasmapheresis using periodic backflush containing anticoagulant (2009-01-13),

6. 7354392 - Structurally optimized hollow fiber membranes (2008-04-08),

7. 7267771 - Apparatus for therapeutic apheresis (2007-09-11),

8. 7195711 - Specialized hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration (2007-03-27),

9. 6949078 - Apparatus and method for selective reduction of segmental intracellular and extracellular edema (2005-09-27),

10. 6899692 - Plasmapheresis filter device and catheter assembly (2005-05-31),

11. 6849183 - Method and apparatus for therapeutic apheresis (2005-02-01),

12. 6802971 - Specialized hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration (2004-10-12),

13. 6802820 - Specialized hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration (2004-10-12),

14. 6659973 - Apparatus and method for in-vivo plasmapheresis using periodic backflush (2003-12-09),

15. 6632192 - Apparatus and method for selective reduction of segmental intracellular and extracellular edema (2003-10-14),

Company Overview

Transvivo, Inc. is a biotechnology company based in Napa, California, specializing in the development of innovative medical devices and therapeutics. The organization focuses on advancing solutions for critical health challenges, particularly in the fields of regenerative medicine and tissue engineering. By leveraging cutting-edge research and technology, Transvivo aims to enhance patient outcomes and improve the quality of life through its pioneering products and methodologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

19 Patents

#3 in Napa, CA

#4,108 in California

#17,154 in US

#32,705 in the World

Napa, CA, United States of America

Transvivo, Inc.

Forward Citations = 740

7 inventors:

Reynolds G Gorsuch (19 out of 29 patents)

Harold W Peters (9 out of 15 patents)

Harold H Handley, Jr (9 out of 9 patents)

4. Tommy Gene Cooper (5 out of 20 patents)

5. Henry M Grage (4 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Transvivo, Inc.. Retrieved from https://idiyas.com/company/transvivo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…